Phreesia’s Upside Is Tied to a Heavy Downside Burden

Six risk flags and a deep drawdown history raise questions about the rally’s durability

PHR Phreesia, Inc.

In this report

01

Returns Overview

Period returns, alpha, cumulative performance, distributions

P. 2-3

→

02

Volatility Analysis

Annualized volatility, downside deviation, drawdowns

P. 4-5

→

03

Beta & Correlation

Trailing, upside, downside beta, systematic risk

P. 6-7

→

04

Risk-Adjusted Returns

Sharpe, Sortino, Calmar, Information, Treynor

P. 8-9

→

05

Market Regime Analysis

Bull/bear behavior, capture ratios

P. 10-11

→

06

Investment Highlights & Risk Summary

Executive summary, risk flags, rankings

P. 12-13

→

Returns Overview

Phreesia, Inc. (PHR) — Return Performance

Phreesia, Inc. (PHR) has delivered highly volatile returns across all horizons, with performance markedly lagging its sector benchmark (XLV). Over the past month the stock fell 3.25% versus a sector loss of 5.61%, generating modest alpha of -0.66%; the three‑month gain of 13.84% still trailed the sector’s 9.48% outperformance, yielding a small positive alpha of 0.74%. The longer horizons show deep underperformance: six‑month, one‑year, two‑year, three‑year and five‑year returns are all negative double‑digits, with cumulative underperformance (alpha) ranging from -42.46% to -156.25% versus the sector, indicating that any short‑term bounce has not translated into sustained upside.

Period Returns vs S&P 500 & XLV

Monthly Returns Heatmap

PHR

The stock’s return profile is characterized by a brief three‑month outperformance but quickly reverses to steep declines, delivering -66.48% over the past year and -84.44% over five years. Alpha versus the XLV sector is consistently negative beyond the one‑month window, reflecting that Phreesia has failed to generate excess returns relative to its healthcare peers across both medium and long horizons.

Returns Overview

Phreesia, Inc. (PHR) — Return Charts

Volatility Analysis

Phreesia, Inc. (PHR) — Volatility Profile

Phreesia, Inc. (PHR) exhibits markedly higher price fluctuation than the broader market, with an annualized volatility of 59.64% compared with the S&P 500’s 17.78%, indicating roughly three‑times the risk per unit of time. The stock’s downside profile is equally pronounced: a downside deviation of 43.1% and a historic maximum drawdown of -90.0% over a five‑year window reflect severe loss potential and an extended recovery period that has not yet materialized. Recent short‑term volatility remains elevated, as the 60‑day vol of 79.0% exceeds both the 252‑day average (56.97%) and the long‑run level, suggesting the stock is currently in a heightened risk regime.

Volatility Metrics

PHR

The company’s volatility far outpaces the S&P 500 benchmark, delivering an annualized figure of 59.64% versus 17.78%, which translates into a Sharpe‑like risk premium that is difficult to justify without commensurate returns. Downside risk metrics reinforce this view: a downside deviation of 43.1% and a max drawdown of -90%—spanning from the February 2021 peak to the April 2026 trough—highlight both depth and duration of loss, with no observable recovery to date. Moreover, the trailing 60‑day volatility (79.0%) sits well above the longer‑term 252‑day average (56.97%), indicating that recent market sentiment has amplified price swings beyond the historical norm.

PHR’s annualized volatility is more than three times that of the S&P 500.
Downside deviation stands at 43.1%, underscoring a pronounced asymmetry toward losses.
The stock has endured a -90% max drawdown with no recovery over five years, signaling extreme tail risk.
Short‑term (60‑day) volatility is significantly higher than the long‑term (252‑day) average, pointing to an elevated current risk environment.

Positive Characteristics
When volatility spikes are short‑lived, they can create opportunities for high‑conviction traders who seek large price moves.
The substantial divergence between short‑term and long‑term vol could allow strategic positioning if the stock reverts to its historical volatility regime.

Volatility Analysis

Phreesia, Inc. (PHR) — Volatility & Drawdown Charts

Beta & Correlation

Phreesia, Inc. (PHR) — Beta Profile

Phreesia, Inc. (PHR) exhibits a trailing beta of 1.21 versus the S&P 500, placing it at the upper edge of the market‑like range (0.8‑1.2) and bordering on aggressive exposure. This indicates that, on average, the stock moves roughly 21% more than the broad market in either direction, reflecting heightened sensitivity to overall equity sentiment. However, the asymmetric beta profile—upside beta of 0.719 versus downside beta of 1.283—reveals a pronounced skew: the share tends to rise less aggressively in bullish markets while falling more sharply during downturns, a pattern that risk‑averse investors should monitor closely. The modest R-squared of 0.167 and correlation of 0.408 with the S&P 500 suggest that only about 17% of PHR’s price variation is explained by market movements; the remaining 83% is idiosyncratic, offering potential diversification benefits. When benchmarked against its healthcare sector (XLV), the stock’s sector beta of 1.029 indicates near‑par parity with sector trends, yet a low sector correlation of 0.306 and R² of 0.093 imply that sector dynamics account for merely 9% of price variance. Consequently, most of PHR’s risk stems from company‑specific factors rather than broader market or industry forces.

Beta & Correlation Metrics

PHR

The trailing beta of 1.21 signals that Phreesia is slightly more volatile than the S&P 500, aligning with a market‑like risk profile but edging toward aggressive exposure. The pronounced downside beta (1.283) compared with upside beta (0.719) underscores an asymmetric risk pattern: investors may experience larger losses in bear markets while gains are muted in bull runs. With an R-squared of 16.7%, the stock’s movements are largely driven by idiosyncratic factors, offering diversification but also requiring careful company‑specific analysis.

Trailing beta of 1.21 places Phreesia at the high end of market‑like risk.
Downside beta (1.283) exceeds upside beta (0.719), indicating sharper declines than advances.
R-squared of 16.7% means only a small fraction of price movement is explained by the S&P 500.
Idiosyncratic risk accounts for 83.3% of total variance, suggesting strong diversification potential.
Sector beta (1.029) mirrors sector exposure, yet low sector R² (9.3%) shows limited influence from healthcare trends.

Positive Characteristics
Near‑par sector beta indicates the stock captures broad healthcare industry upside when it occurs.
High idiosyncratic component provides diversification benefits for portfolios heavily weighted to market risk.
Modest overall market correlation (0.408) reduces systematic spillover from broader equity swings.

Beta & Correlation

Phreesia, Inc. (PHR) — Rolling Beta

Positive Notes

Near‑par sector beta indicates the stock captures broad healthcare industry upside when it occurs.

High idiosyncratic component provides diversification benefits for portfolios heavily weighted to market risk.

Modest overall market correlation (0.408) reduces systematic spillover from broader equity swings.

Risk-Adjusted Returns

Phreesia, Inc. (PHR) — Risk-Adjusted Performance

Phreesia, Inc. (PHR) delivers a risk-adjusted return profile that is essentially flat relative to the risk‑free rate, as reflected by its Sharpe ratio of 0.005. The marginally higher Sortino ratio of 0.007 indicates that downside volatility is only slightly less pronounced than total volatility, suggesting limited protection against adverse moves. However, the Calmar ratio of 0.044 points to a severe historical drawdown relative to the modest average return, while the negative Information Ratio (-0.206) signals that the stock has underperformed its benchmark on an risk‑adjusted basis. The Treynor ratio of 0.246 shows a small positive premium for bearing systematic market risk, but this is insufficient to offset the broader deficiencies in risk-adjusted performance.

Risk-free rate: 3.63% (Fed Funds Rate)

Risk-Adjusted Metrics

PHR

The Sharpe and Sortino ratios are both near zero, indicating that Phreesia’s excess return over the 3.63% risk‑free rate is negligible when adjusted for total or downside volatility. The slight edge of the Sortino ratio suggests a marginally better handling of downside risk, yet the benefit is minimal in absolute terms. A Calmar ratio of 0.044 reveals that the firm has experienced deep drawdowns relative to its average return, highlighting vulnerability during market stress. The negative Information Ratio underscores an inability to generate consistent alpha against its benchmark, implying that active management or stock selection has not added value. While the Treynor ratio shows a modest reward for systematic risk exposure, it does not compensate for the overall weak risk‑adjusted outcomes.

Sharpe ratio of 0.005 indicates virtually no excess return per unit of total risk.
Sortino ratio of 0.007 is only marginally higher than Sharpe, showing limited downside protection.
Calmar ratio of 0.044 reflects severe drawdown severity relative to average returns.
Information Ratio of -0.206 signals underperformance versus the benchmark on a risk‑adjusted basis.
Treynor ratio of 0.246 provides only a small premium for systematic market exposure.

Positive Characteristics
The Sortino ratio marginally exceeds the Sharpe ratio, suggesting a slightly better downside risk profile.
A positive Treynor ratio indicates that Phreesia does earn a modest return for bearing market beta.

Risk-Adjusted Returns

Phreesia, Inc. (PHR) — Rolling Sharpe & Sortino

Positive Notes

The Sortino ratio marginally exceeds the Sharpe ratio, suggesting a slightly better downside risk profile.

A positive Treynor ratio indicates that Phreesia does earn a modest return for bearing market beta.

Market Regime Analysis

Phreesia, Inc. (PHR) — Regime Behavior

Phreesia, Inc. demonstrates modest outperformance in bullish environments, delivering an average monthly return of 2.75% during Bull-HighVol periods and 2.21% in Bull-LowVol phases. However, its performance deteriorates sharply when markets turn bearish, with a severe -34.39% loss in Bear‑LowVol months and a still sizable -6.37% decline in Bear‑HighVol months. The upside capture of 69.1% coupled with a downside capture of 128.1% yields a capture ratio of 0.54, indicating that the stock captures less than two‑thirds of market gains while suffering more than one‑quarter greater losses on declines.

Current Market Regime: Bull-HighVol

Bull-LowVol = calm uptrend • Bull-HighVol = volatile uptrend • Bear-LowVol = orderly decline • Bear-HighVol = crisis

Regime Returns & Capture Ratios

PHR

In Bull-LowVol regimes, Phreesia’s 2.21% average monthly return suggests steady growth that tracks the broader market but lags behind it, reflecting its reliance on expanding healthcare payer and provider spending. The higher 2.75% return in Bull-HighVol periods shows that volatility amplifies the company’s upside potential, likely due to heightened investor appetite for growth‑oriented health‑tech names during market rallies. Conversely, the -34.39% loss in Bear-LowVol months signals extreme vulnerability when the S&P declines calmly, as investors rotate out of discretionary technology stocks; even in Bear-HighVol periods the stock still falls -6.37%, underscoring limited defensive characteristics.

Market Regime Analysis

Phreesia, Inc. (PHR) — Regime & Capture Charts

Regime Timeline

Phreesia’s upside capture (69.1%) is well below the S&P benchmark of 100%, indicating it lags market gains in all regimes.
Downside capture (128.1%) exceeds 100%, meaning the stock loses more than the market during declines, especially pronounced in Bear‑LowVol months.
The overall capture ratio of 0.54 confirms a net asymmetry: downside risk outweighs upside potential.
Current Bull-HighVol conditions favor Phreesia’s higher average return (2.75%), but the elevated volatility also magnifies its downside exposure if the regime shifts.

Positive Characteristics
Phreesia generates its strongest monthly returns during volatile bull markets, suggesting it can benefit from heightened market enthusiasm for health‑tech growth.
Even in Bear-HighVol periods, losses are limited to -6.37%, which is less severe than the -34.39% observed in calm bear markets.

Investment Highlights & Risk Summary

Phreesia, Inc. (PHR) — Summary & Implications

Phreesia, Inc. (PHR) has delivered a stark 1‑year total return of -66.48%, trailing the S&P 500 by an alpha of -85.48% and underperforming its healthcare sector ETF (XLV) by -81.01%. The stock’s risk profile is dominated by extreme volatility (annualized 59.64%) and a historic max drawdown of -90.0%, indicating substantial capital loss potential. Risk metrics such as a Sharpe ratio of 0.005, Sortino of 0.007, and downside capture of 128.1% underscore that the stock has generated negligible excess return per unit of risk while amplifying market declines. Despite these challenges, Phreesia’s beta of 1.21 suggests it moves more than the broader market, offering a modest upside capture of 69.1% for investors seeking exposure to potential recovery in the digital health workflow space.

Summary Dashboard

Investment Highlights

Upside capture of 69.1% indicates that when the market rises, Phreesia participates in a majority of those gains despite overall underperformance.
Beta of 1.21 reflects higher sensitivity to market movements, which could translate into amplified upside if broader equity sentiment improves.
The company operates within the rapidly expanding digital health and patient intake automation segment, providing a long‑term growth narrative beyond short‑term price performance.

Risk-Return Rankings

PHR HIGH

High volatility and deep drawdown dominate the risk profile, outweighing modest upside capture.

Strength: Potential for outsized gains if healthcare digital adoption accelerates and market sentiment rebounds.

Concern: Extreme downside risk reflected by a 90% max drawdown and 128.1% downside capture.

Key Takeaways

The stock’s Sharpe (0.005) and Sortino (0.007) ratios are near zero, indicating almost no reward for the risk taken.
Downside capture exceeds 100%, meaning Phreesia loses more than the market on down days, a critical asymmetry for risk‑averse investors.
Sector underperformance of -81% suggests company‑specific challenges beyond broader healthcare trends.
High annualized volatility (59.6%) places the stock well above the S&P 500’s typical 17% range, demanding a strong risk tolerance.

PORTFOLIO IMPLICATIONS

Phreesia’s risk profile is best suited for a small, speculative allocation within a diversified equity portfolio that can absorb large drawdowns without jeopardizing overall objectives. Its high beta and upside capture may complement lower‑beta, defensive holdings by providing potential upside in bullish regimes, but the asymmetric downside exposure necessitates tight position sizing and active monitoring of sector dynamics and cash flow trends.

PHR

Related Reports

Visit finexus.net/reports for more reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.